Accelerated Approval of Cancer Drugs: How Many Verify Clinical Benefit?
Dr. Edward Cliff presented a poster on the clinical benefit of cancer drugs granted accelerated approval.
Dr. Edward Cliff presented a poster on the clinical benefit of cancer drugs granted accelerated approval.
The FDA issued 14 oncology approvals this quarter, including the first tumor-infiltrating lymphocyte therapy.
Patricia M. LoRusso and Stacy Shord discuss dosage optimization's current state and how the FDA-AACR workshop will move the...
The AACR Annual Meeting 2023, held April 14-19, commemorated several milestones, including the 25th anniversary of the approval of...
The American Association for Cancer Research (AACR) released its annual Cancer Progress Report today. The report serves as an important record of the...
Earlier this month, the U.S. Food and Drug Administration (FDA) announced that the Office of Hematology and Oncology Products...
Breast cancer can be a scary diagnosis. Even though mortality rates have declined in recent years in the United...
The use of immunotherapy in the treatment of cancer has dramatically increased in the five years since the U.S....
Last week, the U.S. Food and Drug Administration (FDA) approved the second of a new wave of molecularly targeted...
During late spring and early summer, the U.S. Food and Drug Administration (FDA) approved four new molecularly targeted therapeutics—alpelisib...